2674
H. Brunner et al. / Tetrahedron: Asymmetry 12 (2001) 2671–2675
1
2 (2.53 g, 57%). Mp 182°C; [h]2D5=−40.0 (c 1, H2O); H
NMR (250 MHz, D2O): l=3.17 (dd, 1H, J2,1=8.2 Hz,
(2 mL). Acetic anhydride (191 ml, 206 mg, 2 mmol) was
added and the solution was stirred for 16 h at 60°C.
The reaction mixture was poured on ice water (50 mL)
and 20% HCl (10 mL), extracted with CH2Cl2 (3×20
mL) and the combined organic extracts were dried over
MgSO4. Removal of the solvent under reduced pressure
and subsequent chromatography on silica gel eluting
with EtOAc/hexanes 2:1 gave pure 7 as a white solid in
89% yield. Colourless crystals suitable for X-ray dif-
fraction analysis were obtained after recrystallisation
from hexanes/EtOAc. Mp 77°C; [h]2D5=−17.3 (c 3,
J
2,3=9.2 Hz, H-2), 3.24 (dd, 1H, J4,3=8.7 Hz, J4,5=9.6
Hz, H-4), 3.35 (ddd, 1H, J5,6a=2.2 Hz, J5,6b=5.7 Hz,
5,4=9.6 Hz, H-5), 3.38 (dd, 1H, J3,4=8.7 Hz, J3,2=9.2
J
Hz, H-3), 3.60 (dd, 1H, J6b,5=5.7 Hz, J6b,6a=12.3 Hz,
H-6b), 3.81 (dd, 1H, J6a,5=2.2 Hz, J6a,6b=12.3 Hz,
H-6a), 4.44 (d, 1H, J1,2=8.2 Hz, H-1); MS (ESI,
MeOH+1% AcOH): m/z=196.2 (MH+, 100); anal.
calcd for C6H13NO6 (195.2): C, 36.92; H, 6.17; N, 7.18.
Found: C, 36.86; H, 6.94; N, 7.38%.
1
CH2Cl2); H NMR (400 MHz, CDCl3): l=1.97 (s, 3H,
4.3. O-(b-
D
-Glucopyranosyl)-2-diphenylphosphanylbenz-
CH3), 2.01 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.07 (s, 3H,
aldoxime 5
CH3), 3.74 (ddd, 1H, J5,4=9.9 Hz, J5,6a=4.2 Hz, J5,6b
=
=
2.2 Hz, Hgluc-5), 4.08 (dd, 1H, J6b,6a=12.4 Hz, J6b,5
To a solution of 2 (195 mg, 1 mmol) and 2-
diphenylphosphanylbenzaldehyde 3 (290 mg, 1 mmol)
in H2O (20 mL) and THF (20 mL) was added 0.1 M
HCl (1 mL) and the reaction mixture was stirred at
room temperature for 24 h. After removal of the sol-
vents under reduced pressure the residue was taken up
in CH2Cl2 (50 mL), washed with water (2×20 mL) and
brine (1×10 mL) and purified by column chromatogra-
phy on silica gel using CH2Cl2/methanol 12:1 to give
pure 5 as a white solid in 95% yield. Mp 145°C;
[h]2D5=−1.8 (c 3, CH2Cl2); 1H NMR (400 MHz, DMSO-
d6): l=3.05–3.25 (m, 4H, Hgluc), 3.40–3.48 (m, 1H,
Hgluc), 3.57–3.65 (m, 1H, Hgluc), 4.50–4.44 (m, 1H,
2.2 Hz, Hgluc-6b), 4.30 (dd, 1H, J6a,6b=12.4 Hz,
6a,5=4.2 Hz, Hgluc-6a), 5.10–5.27 (m, 4H, Hgluc), 6.90–
J
6.95 (m, 1H, Har), 7.19–7.25 (m, 4H, Har), 7.27–7.40 (m,
8H, Har), 7.83–7.88 (m, 1H, Har), 8.83 (d, 1H, JP=4.4
Hz, CHꢀN); 31P{1H} NMR (400 MHz, CDCl3): l=
−13.94; MS (CI-MS): m/z=288.2 (100), 366.3 (12),
636.3 (MH+, 3); anal. calcd for C33H34NO10P (635.6):
C, 62.36; H, 5.39; N, 2.20. Found: C, 62.10; H, 5.62; N,
2.09%.
4.6. O-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-
pyridine-2-carbaldoxime 8
H
gluc), 4.83 (d, 1H, 3J=8.3 Hz, OH), 4.97 (d, 1H,
Reaction procedure as for 7 with O-(b-D-glucopyran-
J=5.0 Hz, OH), 5.06 (d, 1H, J=4.8 Hz, OH), 5.32 (d,
1H, J=5.2 Hz, OH), 6.81–6.86 (m, 1H, Har), 7.15–7.22
(m, 4H, Har), 7.38–7.44 (m, 7H, Har), 7.44–7.49 (m, 1H,
Har), 7.85–7.89 (m, 1H, Har), 8.74 (d, 1H, JP=4.4 Hz,
CHꢀN); 31P{1H} NMR (400 MHz, CDCl3): l=−14.98;
MS (FAB): m/z=288.2 (100), 468.5 (MH+, 49); anal.
calcd for C25H26NO6P (467.5): C, 64.24; H, 5.61; N,
3.00. Found: C, 64.01; H, 5.82; N, 2.81%.
osyl)pyridine-2-carbaldoxime 6 (107 mg, 0.43 mmol)
gave 8 as colourless needles in almost quantitative
1
yield. Mp 117°C; [h]2D5=−22.0 (c 2, CH2Cl2); H NMR
(250 MHz): l=2.03 (s, 3H, CH3), 2.04 (s, 3H, CH3),
2.05 (s, 3H, CH3), 2.08 (s, 3H, CH3), 3.85 (ddd, 1H,
J
5,4=9.8 Hz, J5,6a=4.3 Hz, J5,6b=2.4 Hz, Hgluc-5), 4.15
(dd, 1H, J6b,6a=12.4 Hz, J6b,5=2.4 Hz, Hgluc-6b), 4.33
(dd, 1H, J6a,6b=12.4 Hz, J6a,5=4.3 Hz, Hgluc-6a), 5.13–
5.39 (m, 4H, Hgluc), 7.31 (ddd, 1H, J2,3=6.5 Hz, J2,1
4.9 Hz, J2,4=2.3 Hz, Hpy-2), 7.72 (ddd, 1H, J3,4=7.9
Hz, J3,2=6.7 Hz, J3,1=1.7 Hz, Hpy-3), 7.76 (ddd, 1H,
=
4.4. O-(b-D-Glucopyranosyl)pyridine-2-carbaldoxime 6
Obtained as above from pyridine-2-carbaldehyde 4 and
2 without using THF as a co-solvent and after chro-
matography on silica gel using EtOAc/methanol 7:3 to
give pure 6 as a white hygroscopic powder in 92% yield.
J
4,3=7.9 Hz, J4,2=2.3 Hz, J4,1=1.0 Hz, Hpy-4), 8.27 (s,
1H, CHꢀN), 8.65 (ddd, 1H, J1,2=4.9, J1,3=1.7, J1,4
=
1.0, Hpy-1); MS (CI-MS): m/z=107.0 (100), 246.1 (23),
453.2 (MH+, 41); anal. calcd for C20H24N2O10 (452.4):
C, 53.10; H, 5.35; N, 6.19. Found: C, 53.10; H, 5.39; N,
6.20%.
1
Mp 76°C; [h]2D5=−16.3 (c 2, CH3OH); H NMR (250
MHz, D2O): l=3.30–3.43 (m, 1H, Hgluc), 3.44–3.55 (m,
3H, Hgluc), 3.63 (dd, 1H, J6a,6b=12.3 Hz, J=5.8 Hz,
H
gluc-6a), 3.82 (dd, 1H, J6b,6a=12.3 Hz, J=2.14, Hgluc-
6b), 5.07–5.12 (m, 1H, Hgluc), 7.39 (ddd, 1H, J2,3=7.6
Hz, J2,1=5.0 Hz, J2,4=1.3 Hz, Hpy-2), 7.68 (ddd, 1H,
4.7. Crystal data for compound 7
J
4,3=7.9 Hz, J4,2=1.3 Hz, J4,1=0.9 Hz, Hpy-4), 7.81
C33H34NO10P 7: colourless thin rod from EtOAc/
hexanes, Fw=635.58, monoclinic, space group P21 (no.
(ddd, 1H, J3,4=7.9 Hz, J3,2=7.6 Hz, J3,1=1.7 Hz,
Hpy-3), 8.29 (s, 1H, CHꢀN), 8.45 (ddd, 1H, J1,2=5.0
Hz, J1,3=1.7 Hz, J1,4=0.9 Hz, Hpy-1); MS (CI-MS):
m/z=107.0 (100), 122.0 (48), 285.2 (MH+, 4); anal.
calcd for C12H16O6N2 (284.3): C, 50.70; H, 5.67; N,
9.85. Found: C, 50.43; H, 5.78; N, 9.65%.
,
4), a=14.300(1), b=7.6003(5), c=15.008(1) A, i=
3
−3
,
96.135(9)°, V=1621.8(2) A , Z=2, Dx=1.301 Mg m ,
v(Mo-Ka)=0.142 mm−1, crystal dimensions 0.46×0
.20×0.08 mm3, u=0.71073
,
A (Mo-Ka radiation,
graphite monochromator, STOE Imaging Plate Diffrac-
tion System). Data collection at T=173 K, 1.87<q<
25.73°, h −1717, k −99, l −1818, 16306 reflections
measured, 6134 unique, merging Rint=0.0486). The
structure was solved by direct methods (SIR-976) and
refined by full-matrix least-squares based on F2
(SHELXL-977) with weights w=1/[|2(Fo)2+(0.0723P)2],
4.5. O-(2,3,4,6-Tetra-O-acetyl-b-
diphenylphosphanylbenzaldoxime 7
D-glucopyranosyl)-2-
O-(b-
D-Glucopyranosyl)-2-diphenylphosphanylbenzald-
oxime 5 (200 mg, 0.43 mmol) was dissolved in pyridine